Nuveen Churchill Direct Lending Corp. (NCDL) stock intrinsic value fair value estimate & owner earnings analysis

Nuveen Churchill Direct Lending is a business development company that lends to U.S. middle-market companies owned by private-equity firms and pays out most of its income as dividends. At June 30, 2026 it held $1.92 billion of investments across 244 companies in 26 industries, about 89.6% of them first-lien senior loans (7.3% subordinated debt, 3.1% equity). It had $849 million of shareholders' equity (net asset value of $17.19 per share, down from $17.50 in March and $17.72 at the end of 2025) and $1.09 billion of borrowings, about 1.29 times equity. It is externally managed: the adviser earns a base fee of 1.00% plus incentive fees. How we measure earnings: a lender's cash-flow statement is dominated by loans made and repaid, so we treat those flows as reinvestment rather than earnings. We start from net investment income after excise tax, remove payment-in-kind interest (income accrued but not yet received in cash), and subtract realized credit losses. Borrowing costs, including recurring fees to arrange financing, are treated as ordinary costs. Result per share: $1.63 (2021), $1.91 (2022), $2.17 (2023), $1.86 (2024), $1.54 (2025). We do not use 2023-2024 as the starting level: those years had peak short-term rates and, after the January 2024 listing, waived incentive fees and a reduced 0.75% base fee (worth about $0.41 per share in 2024). Starting level: in the first half of 2026, net investment income was $40.3 million and payment-in-kind interest $5.5 million, so cash-based income was $1.41 per share annualized; the second quarter alone ran at $1.44. Realized losses were $14.6 million in the first half ($0.29 per share), plus $13.4 million of unrealized losses. Credit worsened in the second quarter: loans on non-accrual rose from five companies (1.3% of the portfolio at cost) at March 31 to nine (2.7% at cost, 1.5% at fair value) at June 30, and the portfolio yield at cost was 9.3%, down from 10.1% a year earlier. On the other side, the Federal Reserve raised short-term rates by a quarter point in September 2026; because the company's borrowings are also largely floating (it swaps its fixed-rate notes to floating, including the $100 million of 6.65% notes added in July 2026), only the equity-funded part of the book benefits, worth an estimated $0.04 per share a year. Owner earnings fell about 17% in 2025; the base case assumes about a 27% fall in its first year, to $1.12, in line with what 2026 results and the new non-accruals already show. Debt: for a lender, borrowing is the raw material of the business and interest is an ordinary operating cost, so we value earnings after interest and do not subtract the debt again. The net asset value returned at the end of each case is already after all borrowings. In July 2026 the company repaid one loan securitization in full at par (about $302.5 million with interest), added $100 million of notes due 2030 and moved $148.9 million of loans into a new joint venture; nothing material matures before 2029. Asset coverage at June 30 was about 178% against a 150% legal minimum. Each case's value belongs to shareholders after the $1.09 billion owed is repaid in full: about $895 million in the base case, $654 million in the downside case and $1.01 billion in the upside case. No case shows the company owing more than it is worth. Base case (about $18.12 per share): cash-based income of about $1.48 per share (second-quarter run rate plus the rate increase), less about $0.06 for income lost on the new non-accruals, less realized losses. Losses run at $0.30 per share a year in 2027-2028 while the current problem loans are worked out, giving owner earnings of $1.12, then return to the roughly $0.20 a year averaged since 2022, giving $1.22 for the following 13 years. After 15 years, 90% of today's net asset value ($15.47 per share) is returned, the discount reflecting that the loans are valued without market prices and that a wind-down has costs. Earnings contribute about $11.67 per share and net asset value about $6.46. No growth is credited: the share count is flat at 49.4 million, new loans are funded from repayments, and the new joint venture is too new to have a record. Downside case (about $13.24): one full credit downturn of the kind middle-market lenders went through in 2008-2010, starting from today's rising non-accruals. Owner earnings are $0.78 in 2027 (first-half 2026 loss pace continuing), then about $0.05 in each of 2028 and 2029 as realized losses of roughly 3% of the loan book a year consume almost all income, $0.54 in 2030 as losses ease, and $1.00 a year for 2031-2036 on a smaller, more cautiously run book. Cumulative realized losses come to roughly 8.5% of today's portfolio. On top of that, a markdown of the remaining loans in the trough, as in 2008-2009, would push asset coverage below the 150% minimum, forcing loan sales or new shares issued below net asset value; we charge this as a permanent loss, leaving net asset value of $14.50 per share after ten years. Earnings contribute about $5.15 and net asset value about $8.10. This is below today's net asset value. Upside case (about $20.38): cash-based income of about $1.48 per share and realized losses stay at the 2025 level of $0.12, giving $1.36 per share for 15 years, followed by return of the full $17.19 net asset value. Earnings contribute about $13.21 and net asset value about $7.17. No return to 2023-2024 earnings is credited. What changed since our previous analysis: the base value moves from $18.21 to $18.12 and the downside from $14.88 to $13.24. Non-accruals roughly doubled in the second quarter, so we now carry higher losses for two years in the base case and a full credit-cycle downturn in the downside case; the September rate increase partly offsets this. The upside case is unchanged. Price judgement: we are reasonably sure of today's income level, which is reported quarterly in cash terms, but not of credit losses, which are the swing factor and are now rising. The worst plausible outcome is a severe downturn among sponsor-backed borrowers that forces the company to sell loans or issue shares at depressed prices; the company would very likely survive it, since its debt is long-dated and spread across a revolver, securitizations and unsecured notes, but shareholders would lose a meaningful slice of book value. If we are wrong about losses and about how much of the book is really worth its stated value, the shares are worth roughly the downside's $13.24. The price assumes about a four-year holding period, with distributions paid along the way (the third-quarter 2026 distribution is $0.38 per share). The margin-of-safety price is $10.50: from that price the base case implies about 23% a year over four years (about 29% over three), counting only owner earnings as cash, and the downside case implies roughly 13% a year. Above about $11 the base-case implied return slips below our target over a four-year holding period, which is why the margin-of-safety price is not higher.